BARDA BID 2021 Logo
BARDA INDUSTRY DAY
November 3-4, 2021     Virtual Event

Strengthening Partnerships, Advancing Innovation

Presentation videos are available!

VIEW PRESENTATIONS
WHAT IS BARDA INDUSTRY DAY?

BARDA Industry Day is our annual conference, held to increase awareness of U.S. government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in the health security space. During BARDA Industry Day 2020, the one-day virtual event attracted 1300+ attendees, featured BARDA program goals and funding updates, expert presentations from government and industry partners, 13 interactive breakout sessions, and two Lightning Talk sessions showcasing 20 exciting technologies.

Read More
icon multiple people Multiple Networking Opportunities
icon of star Priorities
icon hands shaking Industry Partners
icon of light bulb Innovation
icon of door wiht arrow Industry & Government Access
icon of fire shaped message cloud Fireside Chat
Presentation Icon

Presentations

DAY 1 | MORNING PLENARY & PROGRAM OVERVIEW SESSIONS
PREPARING FOR NEXT PANDEMIC STARTING NOW
DAY 2 | MORNING PLENARY SESSIONS
TRACK 1 - BREAKOUT SESSION I
TRACK 2 - BREAKOUT SESSION I
TRACK 1 - BREAKOUT SESSION II
TRACK 3 - BREAKOUT SESSION I
TRACK 2 - BREAKOUT SESSION II
TRACK 3 - BREAKOUT SESSION II
TRACK 1 - BREAKOUT SESSION III
TRACK 2 - BREAKOUT SESSION III
TRACK 3 - BREAKOUT SESSION III
TRACK 1 - BREAKOUT SESSION I
TRACK 2 - BREAKOUT SESSION I
TRACK 3 - BREAKOUT SESSION I
TRACK 1 - BREAKOUT SESSION II
TRACK 2 - BREAKOUT SESSION II
TRACK 3 - BREAKOUT SESSION II
TRACK 1 - BREAKOUT SESSION III
TRACK 3 - BREAKOUT SESSION III
TRACK 1 - BREAKOUT SESSION IV
TRACK 3 - BREAKOUT SESSION IV
TRACK 3 - BREAKOUT SESSION IV
VIDEO SESSION
DAY 1
Watch Video DAY 1 | MORNING PLENARY SESSIONS
00:01:30 – 00:04:13 BARDA WELCOME: Linda Lambert, PhD, Deputy Director, Biomedical Advanced Research & Development Authority & Director, Medical Countermeasures Program Support Services
00:04:14 – 00:11:38 ASPR WELCOME: Dawn O'Connell, JD, Assistant Secretary for Preparedness and Response
00:11:39 – 00:20:01 GOVERNMENT PARTNER – Marcella Nunez-Smith, MD, MHS
Chair, Presidential COVID-19 Health Equity Task Force
00:20:02 – 00:31:19 GOVERNMENT PARTNER – Jason Roos, PhD
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRN)
00:31:20 – 00:46:42 INDUSTRY PARTNER: Matteo Lai, MSc, MS
Co-founder and Chief Executive Officer of Empatica
00:46:43 – 00:50:04 INDUSTRY PARTNER: Stephane Bancel, MS, MBA
Chief Executive Officer of Moderna, Inc
00:50:05 – 01:14:01 BARDA DIRECTOR’S UPDATE - Gary Disbrow, PhD
Director, Biomedical Advanced Research and Development Authority (BARDA)
DAY 1 | PROGRAM OVERVIEWS
01:14:02 – 01:27:45 Chemical, Biological, Radiological and Nuclear (CBRN): Chris Houchens, PhD, Director
01:27:46 – 01:50:10 Influenza and Emerging Infectious Diseases (IEID): Ruben Donis, PhD, (Acting) Director
01:50:11 – 02:01:59 Division of Research, Innovation, and Ventures (DRIVe): Sandeep Patel, PhD, Director
02:02:00 – 02:11:23 Contract Management & Acquisition (CMA): Matthew McCord, JD, Chief Contracting Officer
BREAKOUT SESSION I
Watch Video Track 1: Chemical, Biological, Radiological and Nuclear Divisional Breakout
  • Antivirals & Antitoxins Program
  • Vaccines Program
  • Antibacterials Program
  • Watch Video Track 2: Division of Research, Innovation, and Ventures Divisional Breakout (LIVE)
    Watch Video Track 3: Regulatory and Quality Affairs Divisional Breakout
    BREAKOUT SESSION II
    Watch Video Track 1: Influenza and Emerging Infectious Diseases Divisional Breakout
    Watch Video Track 2: Division of Research, Innovation, and Ventures & Global Health Investment Corporation Breakout (LIVE)
    Watch Video Track 3: MCM Procurement Under PBS Contracts: Regulatory and Quality Affairs Considerations Breakout
    BREAKOUT SESSION III
    Watch Video Track 1: Lightning Talks 1
    Watch Video Track 2: Early-Stage Product Development Simulation Breakout
    Watch Video Track 3: Leveraging Experience with Pandemic Influenza Vaccines for Emerging Infectious Disease Preparedness
    Watch Video Preparing for the Next Pandemic Starting Now
    DAY 2
    Watch Video DAY 2 | MORNING PLENARY SESSIONS
    00:00:00 – 00:01:12 WELCOME BACK: Linda Lambert, PhD, Deputy Director, Biomedical Advanced Research & Development Authority & Director, Medical Countermeasures Program Support Services
    00:01:13 – 00:21:03 KEYNOTE SPEAKER–Trevor Mundel, MD, President, Global Health Division, Bill & Melinda Gates Foundation
    00:21:04 – 00:30:38 HIGHLIGHTED SPEAKER–Kathleen Neuzil, MD, MPH, FIDSA, Director of the Center for Vaccine Development and Global Health University of Maryland School of Medicine
    00:30:39 – 00:55:40 FIRESIDE CHAT–Dawn O'Connell, JD Assistant Secretary for Preparedness and Response and Dr. Gary Disbrow, BARDA Director
    DAY 2 | PROGRAM OVERVIEWS
    00:55:41 – 01:00:19 Detection, Diagnostics, & Devices Infrastructure (DDDI): Rodney Wallace, Director
    01:00:20 – 01:09:50 Division of Nonclinical Development (NCD): April Brys, PhD, Director
    01:09:51 – 01:14:06 Division of Clinical Development (DCD): Rich Gorman, MD (Acting) Director
    01:14:07 – 01:19:03 Pharmaceutical Countermeasures Infrastructure (PCI): Michael Angelastro, Director
    BREAKOUT SESSION I
    Watch Video Track 1: Chemical, Biological, Radiological and Nuclear Divisional Breakout
  • Burn & Blast Medical Countermeasures
  • Radiological & Nuclear Countermeasures Program
  • Chemical Medical Countermeasures
  • Watch Video Track 2: Impact of the COVID-19 Pandemic on Future Clinical Trials and the BARDA Clinical Studies Network Breakout
    Watch Video Track 3: Pharmaceutical Countermeasures Infrastructure (PCI) Divisional Breakout
    BREAKOUT SESSION II
    Watch Video Track 1: Detection, Diagnostics, & Devices Infrastructure (DDDI) Divisional Breakout
    Watch Video Track 2: Leveraging Nonclinical Partnerships To Address Critical and Emerging Threats Breakout
    Watch Video Track 3: On Demand Manufacturing Breakout
    BREAKOUT SESSION III
    Watch Video Track 1: Therapeutic Development for ARDS Breakout
    Watch Video Track 2: Repurposing Drugs in Response to Chemical Threats (ReDIRECT) Program Breakout
    (No Session Scheduled) Track 3
    BREAKOUT SESSION IV
    Watch Video Track 1: Lightning Talks II
    Watch Video Track 2: Next Generation Nonclinical Tools for Advancing Medical Countermeasure Development Breakout
    Watch Video Track 3: BARDA Partnership with JPEO-CBRN
    icon of person at podium

    Our Featured Speakers

    Follow us on social media or sign-up for email updates to stay informed when we announcement our speakers!

    Dawn O'Connell
    Dawn O'Connell, JD

    Assistant Secretary for Preparedness & Response
    U.S. Department of Health & Human Services

    Marcella Nunez-Smith, MD, MHS.
    Marcella Nunez-Smith, MD, MHS

    Chair
    Presidential COVID-19 Health Equity Task Force

    Matteo Lai
    Matteo Lai, MSc, MS

    Co-Founder and CEO
    Empatica

    Stéphane Bancel
    Stéphane Bancel, MS, MBA

    Chief Executive Officer
    Moderna

    Jason W. Roos, PhD
    Jason W. Roos, PhD

    Joint Program Executive Officer for
    Chemical, Biological, Radiological & Nuclear Defense

    Gary L. Disbrow
    Gary L. Disbrow, PhD

    Director, BARDA
    U.S. Department of Health & Human Services

    Kathleen Neuzil
    Kathleen Neuzil, MD, MPH, FIDSA

    Director of the Center for Vaccine
    Development and Global Health
    University of Maryland School of Medicine

    Trevor Mundel
    Trevor Mundel, MD, PhD

    President, Global Health Division
    Bill & Melinda Gates Foundation

    LIGHTNING TALKS
    SHOWCASING INNOVATIVE DISCOVERIES AND NETWORKING
    BID 2021 SELECTEES
    BARDA Industry Day

    GET BID 2021 EMAIL UPDATES

    To receive updates about BARDA Industry Day and other news, enter your email address.

    CONNECT WITH US

    PRESENTED BY
    HHS, ASPR BARDA Logos
    t